Effects of bone morphogenetic protein-2 and hyaluronic acid on the osseointegration of hydroxyapatite-coated implants: An experimental study in sheep

被引:51
作者
Aebli, N
Stich, H
Schawalder, P
Theis, JC
Krebs, J
机构
[1] Princess Alexandra Hosp, Dept Orthopaed Surg, Woolloongabba, Qld 4102, Australia
[2] Univ Bern, Sch Dent, CH-3010 Bern, Switzerland
[3] Univ Bern, Fac Vet, CH-3012 Bern, Switzerland
[4] Univ Otago, Dept Orthopaed Surg, Dunedin, New Zealand
关键词
osseointegration; BMP-2; implant fixation; hydroxyapatite;
D O I
10.1002/jbm.a.30299
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Research efforts aim at enhancing early osseointegration of cementless implants to improve early fixation and, thus, reduce the risk of loosening. The aim of the present study was to investigate whether bone morphogenetic protein (BMP) 2 had a positive effect on the osseointegration of hydroxyapatite-coated implants. Hydroxyapatite (HA) implants (perforated hollow cylinders and solid rods) were coated with BMP-2 and hyaluronic acid (HY) as the carrier or with HY alone. Uncoated HA implants served as controls. The osseointegration of the implants was evaluated either by light microscopy or by pullout tests after 1, 2, and 4 weeks of unloaded implantation in the cancellous bone of 24 sheep. The BMP-2 coating significantly increased bone growth into the implant perforations compared with HA-coated implants at 2 and 4 weeks. Bone-implant contact and interface shear strength of BMP-2 implants were lower than HA implants at 2 weeks. At 4 weeks, there was no significant difference in bone-implant contact and shear strength between BMP-2 and HA-coated implants. The BMP-2 coating enhanced gap healing but had no positive or even an inhibitory effect (at 2 weeks) on bone-implant contact and interface shear strength. In the clinical situation, a perfect press-fit implantation cannot be achieved, and BMP-2 may be beneficial for enhancing bone growth into gaps around cementless implants. (c) 2005 Wiley Periodicals, Inc.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 41 条
[1]   In vivo comparison of the osseointegration of vacuum plasma sprayed titanium- and hydroxyapatite-coated implants [J].
Aebli, N ;
Krebs, J ;
Stich, H ;
Schawalder, P ;
Walton, M ;
Schwenke, D ;
Gruner, H ;
Gasser, B ;
Theis, JC .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 66A (02) :356-363
[2]   BONE INGROWTH INTO WEIGHT-BEARING POROUS FIBER TITANIUM IMPLANTS - MECHANICAL AND BIOCHEMICAL CORRELATIONS [J].
BARTH, E ;
RONNINGEN, H ;
SOLHEIM, LF ;
SAETHREN, B .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1986, 4 (03) :356-361
[3]  
BECK LS, 1993, J BONE MINER RES, V8, P753
[4]   Porous-coated metal-backed patellar components in total knee replacement - A postmortem retrieval analysis [J].
Bloebaum, RD ;
Bachus, KN ;
Jensen, JW ;
Scott, DF ;
Hofmann, AA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (04) :518-528
[5]   Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies [J].
Boden, SD ;
Kang, J ;
Sandhu, H ;
Heller, JG .
SPINE, 2002, 27 (23) :2662-2673
[6]   The use of an osteoinductive growth factor for lumbar spinal fusion .2. Study of dose, carrier, and species [J].
Boden, SD ;
Schimandle, JH ;
Hutton, WC .
SPINE, 1995, 20 (24) :2633-2644
[7]  
Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO
[8]  
2-D
[9]   IN-VIVO EVALUATION OF RECOMBINANT HUMAN OSTEOGENIC PROTEIN (RHOP-1) IMPLANTS AS A BONE-GRAFT SUBSTITUTE FOR SPINAL FUSIONS [J].
COOK, SD ;
DALTON, JE ;
TAN, EH ;
WHITECLOUD, TS ;
RUEGER, DC .
SPINE, 1994, 19 (15) :1655-1663
[10]   THE EFFECT OF RECOMBINANT HUMAN OSTEOGENIC PROTEIN-1 ON HEALING OF LARGE SEGMENTAL BONE DEFECTS [J].
COOK, SD ;
BAFFES, GC ;
WOLFE, MW ;
SAMPATH, TK ;
RUEGER, DC ;
WHITECLOUD, TS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1994, 76A (06) :827-838